Good Lifestyle

Ozempic stormed the world in the past year. While the Semaglutide injection was approved by the US Food and Drug Administration (FDA) as treatment for people with type 2 diabetes, its popularity has recently flipped, while celebrities began to take the medicine out of AM pierce . But like ozempic and other drugs as they have become more widespread, patients have started to report unexpected and painful symptoms that can be linked to the medication. Now the Ozempic manufacturer is prosecuted. Read the rest to find out more about the new trial and the presumed side effect behind.

In relation: Ozempic patients report a new debilitating side effect: "I want me to never touched it."

Ozempic and his Sister Wegovy drugs - which is prescribed for weight loss - are they both popular in the weight loss space because they contain the semaglutide , a drug that works by imitating the natural hormone GLP-1.

This hormone slows down food when it goes through the stomach, which helps reduce people's appetites by making them longer. But problems can occur when he slows digestion Too much, according to CNN.

The point of sale has recently reported several cases of ozempic or Wegovy patients diagnosed with serious stomach conditions. Joanie Knight of Angie, Louisiana, and Emily Wright , a teacher in Toronto, told CNN that they had been diagnosed with severe gastropares, otherwise known as the paralysis of the stomach - which, according to their doctors, was caused or exacerbated by their use of Ozempic .

"I hope that I have never touched it. I hope that I have never heard of my life," Knight told CNN. "It cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It cost me a lot, and it is not worth Not worth it. The price is too high. "

In relation: 4 foods that increase the same weight loss hormone as Ozempic, experts say .

The potential link between semaglutide injections and stomach paralysis is now at the center of a new trial. The law firm of injuries Morgan and Morgan announced on August 2 filed a complaint Against Novo Nordisk, the manufacturer of Ozempic, and Eli Lily and Co., which manufactures a similar weight loss medication called Mounjaro, reported CBS News.

Paul Pennock And Jonathan SEDGH , lawyers at the head of the trial, said that the prosecution was based on patients in Novo Nordisk and Eli Lily to warn patients of the potential side effect of gastropares.

"We believe that these drugs cause these problems. We think that the evidence is sufficient for us to prove it or we would not have deposited the case, and we intend to deposit much more in the days and The coming weeks, "said Pennock at a zoom conference, according to CBS News.

In relation: These are the 5 most common ozempic side effects, according to doctors .

The new trial of Morgan & Morgan represents a case Implying a woman from Louisiana who had taken Ozempic and Mounjaro to the recommendation of her doctor. Jacklyn Bjorklund , 44, has not yet received a diagnosis of gastropareia, but has requested emergency medical treatment due to its paralyzing stomach problems.

"Her problems were so serious that she went to the emergency room several times, including last weekend," Pennock said at the conference. "She even vomited so violently that she lost teeth."

The company is also investigating the injuries of 400 other customers who claim to have developed gastropareia after taking these weight loss drugs. They expect the dispute against these manufacturers to possibly involve Thousands of cases in the USA, Financial time reported. AE0FCC31AE342FD3A1346EBB1F342FCB

"Many people are experiencing constant vomiting," said Pennock. "I don't want to say once a week, I mean every day, all the time. I mean, so bad that these people go to the emergency room for their vomiting."

In relation: For more information, register for our daily newsletter .

Gastropares affects "normal spontaneous movement Among the muscles of your stomach, "which prevents your stomach from emptying itself normally, according to the Mayo clinic. This condition" can interfere with normal digestion, cause nausea, vomiting and abdominal pain ", explains the organization on its website.

But there is nothing on the labels of Ozempique or Wegovy which warns patients of the risks of gastropares, reported CNN.

Despite this, Novo Nordisk, the manufacturer of the two drugs, said Better life In a previous statement according to which gastrointestinal problems are "well-known side effects" of GLP-1 drugs.

"For the semaglutide, the majority of gastrointestinal side effects are light to moderate in gravity and short-term. GLP-1 are known to cause delay in gastric emptying, as indicated in the label of each of our drugs GLP-1 ra. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects, "the statement said.

The drug manufacturer has added: "Patient safety is of the utmost importance for Novo Nordisk. We recommend that patients take these drugs for their approved indications and under the supervision of a health professional. Patients, including adequate information on gastrointestinal side effects in the label. "